Carefully controlled hybridization experiments with probes from a cloned serotype 5 M protein (M5) gene (smp5) were performed with DNA isolated from heterologous M types of group A streptococci, and the homologies detected by hybridization were compared with the ability of anti-pepM5 serum to cross-opsonize heterologous M types. As previously reported (J. R. Scott, S. K. Hollingshead, and V. A. Fischetti, Infect. Immun. 52:609-612, 1986), extensive structural homologies exist among the 3' ends of heterologous M protein genes, but there appears to be an increase in sequence variation as one moves towards the 5' ends. However, a clear, predictive correlation between the hybridization patterns and cross-opsonization was not observed. Antibodies raised to a synthetic peptide corresponding to central, conserved sequences adjacent to the C-terminal sides of the pepsin cleavage sites in M5, serotype 6 M protein, and serotype 24 M protein cross-reacted with heterologous acid-extracted M antigens but were not protective and did not bind to intact streptococcal cells, indicating that these epitopes are inaccessible on the intact cell surface. Removal of the N-terminal half of M5, serotype 6 M protein, or serotype 24 M protein by pepsin exposed the conserved epitope on the cell surface. These results suggest that immunoaccessible protective epitopes are confined to the highly variable N-terminal halves of M proteins and that a single, broadly conserved protective M protein epitope does not exist.
Immunity to group A streptococcal infections in humans is mediated by opsonic antibodies directed almost exclusively against the cell surface M protein (1, 12, 13) . Hence, the M protein has been the target of efforts over the past 50 years to develop a vaccine to protect humans against group A streptococcal infections and their remote nonsuppurative sequelae, namely, poststreptococcal glomerulonephritis and acute rheumatic fever. However, these efforts have been frustrated by the existence of a large number of distinct M protein serotypes and the fact that immunity is generally M serotype specific (1-3, 6, 12, 13) . Cross-protection between M serotypes has been observed in animal studies and in in vitro opsonophagocytic assays (8, 29) , but these have been confined to a very limited number of serotypes, and no broadly conserved protective epitopes have yet been identified. Most immunochemical studies have been performed on pepM antigens, which represent the N-terminal halves of M proteins released from the cell surface by pepsin (2) (3) (4) (5) (6) (7) (8) (9) (10) 19) . More recent studies with intact M protein have identified broadly conserved epitopes in the C-terminal halves of the molecule (15) . However, these epitopes elicit only nonopsonic antibodies and therefore appear to be of no value in a vaccine (15; this study).
Hybridization experiments with DNA probes from various regions of a cloned serotype 6 M protein (M6) gene have detected homology between the central and 3' regions of heterologous M protein genes, whereas a probe from the 5' end of the M6 gene hybridized only to homologous M6 DNA (24) . This result raised the hope that there might be previously unidentified, broadly conserved epitopes in an immu-noaccessible central region of M proteins and that hybridization probes might identify such epitopes (24) . The hybridization experiments with central M6 gene probes were performed under very-low-stringency conditions (34% mismatch), which produced positive hybridization signals against all (13 of 13) of the strains tested. However, variation in these signal intensities (scored as + or +/-) suggested that there might be some variation in the sequence homologies, although this could be due to other factors, such as small differences in the concentrations of target DNAs on the filters. More recently, we compared the complete nucleotide sequences of the serotype 5 M protein (M5), M6, and serotype 24 M protein (M24) genes (20) . While the sequences encoding the C-terminal halves of these M proteins and those encoding the signal peptides are strongly conserved, those encoding the N termini of the processed cell surface proteins are highly variable. In addition, the central regions of M5 and M6 are conserved but are distinct from the corresponding region of M24. (16) . The construction of the M5-containing hybrid plasmids pMK207 and pMK213 and of the streptolysin 0-containing hybrid plasmid pMK157 has been described previously (16, 17) . The following group A streptococcal strains, from the Memphis culture collection, were used: M1-AV, M1-BDII,  M2-44/R64, M3-R 58X, M4-S8241, M5-Manfredo, M6-S43,  M9, M11-54-8, M14-BDII, M15, M18-T18-J17C, M19, M22,  M23-R65-26, M24, M25-P211, M26, M29-2311, M30, 20 ,ug of DNase-free RNase per ml was added, and the solution was incubated at 20°C for 30 min to digest RNA. The solution was phenol extracted twice and chloroform extracted, and the DNA was ethanol precipitated as described above. The dried DNA precipitate was suspended in TE and stored at 4°C. Dot blot hybridization. The cloning and mapping of the smp5 and streptolysin 0 (slo) genes have been described previously (16, 17) . For mapping the cloned smp5 gene, a Bal3l-generated deletion mutant, termed pMK213, the sequence of which extended ca. 70 base pairs (bp) into the 3' end of the M5-coding sequences, was isolated, and the deletion endpoint was defined by introducing a BamHI linker (17) . A HindIII-BamHI fragment of pMK213 consisting of 350 bp of smpS DNA sequences proximal to this deletion endpoint was used as probe 1 (see Fig. 1 ). An adjacent 1.5-kilobase HindlIl fragment which extended 400 bp beyond the 5' end of the spmS gene was used as probe 2, and defined subsections of this fragment were used as probes 3 to 6. Restriction endonuclease-generated fragments of pMK213 and pMK157 were separated by electrophoresis on 0.7% (wt/vol) agarose gels, and appropriate probe fragments were purified from the gels by electrophoresis onto DE81 filters as described previously (11, 17) . Equal quantities of target DNA, estimated from A260/A280 measurements, were denatured as described by Maniatis et al. (18) (20) . Equal counts were added to each filter, and hybridizations were performed as described previously (17) .
Opsonization and ELISAs. Group A streptococcal strains which were demonstrated to express M protein on their cell surface by their resistance to phagocytosis in fresh human blood were tested for their ability to be opsonized by anti-pepM5 sera as described by Dale and Beachey (8) .
Enzyme-linked immunosorbent assays (ELISAs) were performed as described previously (8) .
Chemical synthesis of SM24(311-345)C. A peptide [SM24(311-345)C] identical to residues 311 to 345 of the predicted sequence of M24, except for the addition of a cysteine residue to the C terminus, was synthesized by an automated peptide synthesizer at Peninsula Laboratories, Inc., San Carlos, Calif., and purified by high-performance liquid chromatography. The peptide was sequenced by automated Edman degradation with a model 890C sequencer (Beckman Instruments, Inc., Fullerton, Calif.) as described previously (5).
Immunoblotting. M antigens released from streptococcal cells by hot acid extraction (13) were separated by electrophoresis on 12.5% (wt/vol) sodium dodecyl sulfate-polyacrylamide gels and immunoblotted with the various sera as described previously (23) .
Pepsin digestion. Removal of the N-terminal halves of M proteins from the cell surface by pepsin digestion was carried out as described previously (5) .
RESULTS
Variation in sequence homologies. To examine the extent and locations of possible sequence variations between the central and 3' regions of M protein genes, we used sequences from a cloned M5 gene (smpS) as hybridization probes for DNA isolated from 34 heterologous M types of group A streptococci and representative strains of other streptococci. In addition, a probe consisting of a DNA fragment from within a cloned slo gene, which was known to share extensive homology with DNA isolated from all group A, C, and G strains tested, was used as a positive hybridization control for experiments performed under high-stringency conditions. Duplicate filters were reacted under identical conditions with equal quantities of denatured labeled probes, and the only differences in the washing conditions were in salt concentrations, which determined the stringency of the hybridization. The hybridization results with the various probes are summarized in Fig. 1 , and representative blots are shown in Fig. 2 .
Under low-stringency conditions (ca. 20% mismatch), probe 1, from the 3' end of the smp5 gene, hybridized well to DNA from all of the group A strains tested, including a phenotypically M protein-negative strain ( Fig. 1 and 2 ). However, under high-stringency conditions (ca. 1% mismatch), probe 1 failed to hybridize to DNA from 10 of the strains tested but hybridized well to DNA from the other strains (Fig. 2) . Under identical conditions, the control slo gene probe hybridized well to DNA from all of these strains. Thus, while sequences at the 3' ends of M protein genes appear to be strongly conserved among different serotypes, there is some variation in the sequence homologies in about 30% of the strains. A much greater variation in sequence homologies was observed with more proximal smp5 gene sequences. Under low-stringency conditions, probe 2, which extends upstream from probe 1 to 400 bp beyond the 5' end of the smp5 gene (Fig. 1) , hybridized to DNA from all but one (the serotype 33 M protein strain) of the strains tested, but in many cases the signals were very weak. That this reflects differences in sequence homology was demonstrated by the failure of the probe to hybridize to DNA from half of the strains under high-stringency conditions and the production of strong signals with only very few strains (Fig. 2) . To examine these sequence variations in more detail, we performed lowstringency hybridization experiments (ca. 20% mismatch) with probes representing subsections of probe 2 (Fig. 1) . Probe 3, consisting of 240 bp from the 3' end of probe 2, hybridized to DNA from 21 of 35 strains tested under low-stringency conditions. Probe 4, consisting of 200 bp from the center of the smpS gene but located further upstream than probe 3, hybridized to DNA from only 7 of 35 strains tested (Fig. 1) . Probe 5, which consists of the 250 bp encoding the N terminus of processed cell surface M5, hybridized to DNA from only the homologous M5 strain, consistent with the results previously reported for a probe from the corresponding region of the smp6 gene (24) . An adjacent 650-bp probe representing the region encoding the M5 signal peptide plus 400 bp of 5'-flanking sequences (probe 6) produced a result similar to that with intact probe 2 under low-stringency conditions. Thus, sequence variations between M protein genes appear to increase as one moves from the 3' to the 5' ends of the sequences encoding processed cell surface M protein.
Probes 1, 2, and 3 hybridized to DNA from representative strains of group C and G streptococci and, as with group A smp genes, variations in these homologies among different strains were observed (Fig. 2 and data not shown) . This result is consistent with the suggestion that the M-like proteins known to be expressed by these strains are very similar to the group A streptococcal M proteins (25) . No homology could be detected by hybridization with DNA isolated from group B streptococci, S. mutans, S. faecalis, S. mitis, or S. sanguis.
Relationship between sequence homologies and cross-opsonization. To determine if a predictable relationship exists between conserved smp gene sequences detectable by hybridization and the presence of conserved opsonogenic epitopes in M proteins, we compared the variations in sequence homologies with cross-opsonization of heterologous M types of streptococci. Sixteen heterologous M types which were resistant to phagocytosis in in vitro assays were tested for their ability to be opsonized by polyclonal antipepM5 serum (Table 1) . Only a limited correlation was observed between homologies detected by hybridization probes and cross-opsonization by anti-pepM5 serum. The best correlation was observed in the case of probe 4. Of the seven strains which shared homologous sequences with this probe, four (including the M5 strain) were testable in the opsonization assays, and all four were effectively opsonized by anti-pepM5 serum. However, this probe did not identify all pepM5 cross-reactive epitopes, even under low-stringency conditions, since it did not hybridize to DNA from the serotype 22, 46, 49, and 56 M protein strains (Table 1 ). The DNA sequences corresponding to the regions of pepM5 antigen not encoded by probe 4 were either repeated within probe 4 (the B repeat; Fig. 1 it could be argued that the C-terminal half of an M protein contains cross-reactive opsonogenic epitopes which are not present in pepM antigen and are therefore not detectable in the above-described opsonophagocytic assays. To test this, (Fig. 3) and used it to raise antisera in rabbits. This 35-residue sequence is tandomly repeated 2.5 times in M24 immediately adjacent to the C-terminal side of the pepsin cleavage site (21) and overlaps similarly located repeats in M5 and M6. The overlapping regions of these repeats, which are described in detail elsewhere (20) , are depicted in Fig. 3 . A cysteine residue was added to the C-terminal end of peptide SM24(311-345) to facilitate its covalent linkage to the KLH carrier, and 50 nmol of the conjugated peptide was used to immunize rabbits. Anti-SM24(311-345)C antibodies reacted in immunoblots with acid-extracted M24, M5, M6, and M19 streptococcal antigens, and the synthetic peptide absorbed these cross-reacting antibodies from the immune serum (data not shown). Thus, the SM24(311-345)C peptide contains at least one M protein cross-reactive epitope. In ELISAs, the immune serum reacted very well with the synthetic peptide but not with the pepM24 control ( Table 2 ), indicating that the sera contained high titers of antibodies directed against an epitope(s) adjacent to the C-terminal side of the pepsin cleavage site. However, these antibodies did not react with intact M5, M6, or M24 streptococcal cells ( Table 2 ). Removal of the N-terminal halves of M5, M6, and M24 from the cell surfaces by pepsin digestion allowed the anti-SM24(311-345)C antibodies to bind to all three M types, and the newly exposed epitope was removed by further treatment of the pepsintreated cells with trypsin ( 
Conserved, repeated sequences adjacent to the pepsin cleavage sites in M5, M6, and M24. The amino acid sequences, presented in the single-letter code, were predicted from the DNA sequences of the corresponding smp genes (12, 20, 21) . Repeated sequences are enclosed in boxes. The first and last residues of the repeats are numbered above the sequences. One complete copy of each repeat and the corresponding regions in the other M protein sequences are shown. The residues in M24 and M6 which were identical to the corresponding residue in M5 are denoted by quotation marks. The M5 repeat is repeated 2.7 times, the M24 repeat is repeated 2.5 times, and the M6 repeat is repeated twice. The relationships between these repeats are described in more detail elsewhere (20) . located immediately adjacent to the C-terminal side of the pepsin cleavage site, is masked by the presence of the N-terminal halves of the M proteins and is not accessible to antibodies. Therefore, this epitope would be of no value in a vaccine.
DISCUSSION
The conserved epitopes which have previously been identified in the C-terminal halves of M proteins (15) elicit only nonopsonic antibodies and would therefore be of no value in a vaccine. The C terminus of M protein is closely associated with the cell surface, whereas the N terminus extends outwards from the cell (22) . Epitopes close to the C terminus may be masked by other cell wall components or by the N-terminal half of the M protein (see below), rendering them inaccessible to antibody binding. Alternatively, the ability of M proteins to bind plasma fibrinogen, which contributes to their antiphagocytic properties (26) (27) (28) , may result in the masking of epitopes in the C-terminal halves of the molecules. The hybridization experiments reported here suggest that there is a progressive increase in sequence variation 25, 600 and 6,400, respectively, against the SM24(311-345)C peptide and titers of <200 against both pepM24 and intact M24 cells. These sera were not tested with pepsin-or trypsin-treated cells.
from the 3' to the 5' ends of M protein genes. The most strongly and widely conserved sequences, and therefore those most likely to encode broadly conserved epitopes, are those located closest to the 3' ends of smp genes, although some variations in sequence homologies occur even in this region. Structural requirements for the association of M protein with the cell surface may impose a strong selective pressure for the conservation of these sequences, and the limited variations detected could be reflected by conservative amino acid changes or code degeneracy. The increase in sequence variation as one moves towards the 5' ends of smp genes suggests that the closer an epitope is located to the N terminus of M protein, the less likely is it to be widely conserved. Protective antibodies may impose a selective pressure for variation in sequences corresponding to opsonogenic epitopes, which are exposed on the cell surface, whereas masked, nonprotective epitopes would not be subjected to this selective pressure. This is consistent with our results suggesting that while some nonprotective epitopes are widely conserved among different M serotypes, conservation of opsonogenic epitopes is much more limited.
The ELISAs with intact M5, M6, and M24 streptococci and anti-SM24(311-345)C sera showed that antibodies to conserved M protein epitopes located immediately adjacent to the C-terminal side of the pepsin cleavage site do not bind to intact cells and would therefore not be protective. However, when the N-terminal halves of these M proteins were removed from the cell surface by pepsin, the anti-SM24(311-345)C antibodies were capable of binding to the cells. This result indicates that this conserved sequence retains its antigenicity in cell surface M protein and that the failure of antibodies to bind to this epitope on intact cells is a result of the epitope being masked by the presence of the N-terminal half of the M protein, suggesting that antibodies directed against regions closer to the C terminus, which are likely to be even less accessible on the cell surface, would not be protective. Therefore, all protective M protein epitopes appear to be located proximal to the pepsin cleavage site and would be present in pepM antigen. Previous immunochemical studies on a number of pepM antigens, including pepM5, pepM6, and pepM24, have shown that the protective epitopes located in the N-terminal halves of M proteins are either serotype specific or share only limited M protein cross-reactivities (2-4, 6, 8) . This result is confirmed by the results presented in Table 2 , which shows that only 7 probe 4 or 5 indicates that the specific sequences encoding at least some opsonogenic M protein cross-reactive epitopes are not sufficiently homologous to be readily detectable by hybridization. Therefore, while hybridization probes such as probe 4 may be useful in screening for certain M protein crossopsonogenic epitopes, the identification of all such epitopes will need to rely primarily on immunochemical analysis.
The results presented here suggest that it is unlikely that a single, broadly conserved epitope which could elicit protection against all M types of group A streptococci exists. Therefore, a single, broadly protective M protein vaccine may not be feasible. It may, however, be feasible to construct an M protein vaccine targeted against a limited range of M types prevalent in a particular disease or geographical location by carefully selecting a number of different M protein epitopes. Identification of opsonogenic epitopes which cross-react with at least some distinct M types would limit the number of individual epitopes required, and recombinant DNA techniques could be used to link sequences encoding these epitopes in an attempt to produce multivalent M protein immunogens. Some opsonogenic epitopes in M proteins are known to elicit human heart tissue crossreactive antibodies (4, 9, 10), placing a further restriction on the choice of epitopes. Further immunochemical and structural studies focusing on the immunoaccessible N-terminal regions of M proteins will be required to identify opsonogenic epitopes which cross-react with at least some heterologous M types without also cross-reacting with human host tissues. The availability of anti-pepM5 monoclonal antibodies which cross-react with some M proteins but do not cross-react with human heart sarcolemmal membranes (8) should facilitate the structural definition of such epitopes.
